CETSA-based target engagement of taxanes as biomarkers for efficacy and resistance
The use of taxanes has for decades been crucial for treatment of several cancers. A major limitation of these therapies is inherent or acquired drug resistance. A key to improved outcome of taxane-based therapies is to develop tools to predict and monitor drug efficacy and resistance in the clinical...
Saved in:
Main Authors: | Langebäck, Anette, Bacanu, Smaranda, Laursen, Henriette, Mout, Lisanne, Seki, Takahiro, Erkens-Schulze, Sigrun, Ramos, Anderson Daniel, Berggren, Anna, Cao, Yihai, Hartman, Johan, van Weerden, Wytske, Bergh, Jonas, Nordlund, Pär, Lööf, Sara |
---|---|
Other Authors: | School of Biological Sciences |
Format: | Article |
Language: | English |
Published: |
2021
|
Subjects: | |
Online Access: | https://hdl.handle.net/10356/146225 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Nanyang Technological University |
Language: | English |
Similar Items
-
Monitoring structural modulation of redox-sensitive proteins in cells with MS-CETSA
by: Sun, Wendi, et al.
Published: (2019) -
CETSA screening identifies known and novel thymidylate synthase inhibitors and slow intracellular activation of 5-fluorouracil
by: Almqvist, Helena, et al.
Published: (2018) -
Monitoring structural modulation of redox-sensitive proteins in cells with MS-CETSA
by: Sun, W, et al.
Published: (2019) -
Cryotherapy for Prevention of Taxane-Induced Peripheral Neuropathy: A Meta-Analysis
by: Jia, J, et al.
Published: (2022) -
Risk factors for chemotherapy-induced peripheral neuropathy in patients receiving taxane- and platinum-based chemotherapy
by: Molassiotis, A., et al.
Published: (2021)